Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- May 2018
published in
has subject area
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists
- Aged
- Aged, 80 and over
- Anti-Asthmatic Agents
- Asthma
- Chronic Disease
- Cost of Illness
- Cost-Benefit Analysis
- Drug Therapy, Combination
- Fees, Pharmaceutical
- Female
- Glucocorticoids
- Health Expenditures
- Humans
- Leukotriene Antagonists
- Male
- Medicare
- Practice Guidelines as Topic
- Retrospective Studies
- United States